BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announced that it has received approval...

To read the full story on AllPennyStocks.com, click here.

BriaCell Therapeutics (NASDAQ:BCTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos BriaCell Therapeutics.
BriaCell Therapeutics (NASDAQ:BCTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos BriaCell Therapeutics.